Unfortunately J&J is also actively supporting H1B visas initiative. This makes more difficult for American citizens to get meaningful and reasonably paid jobs here. Government statistics say that about 70% H1B visa recipients are Indian nationals.
Amgen is ran by a bunch of blowhards that need to hear the loudest voice rather than anything of merit.
Anthony in leadership of CDNA has created an environment of that if you dont suck up, youll be ostracized and want to quit.
It's not the job but management and leadership team's lack of integrity and open racism at senior manager & above level. Growth and development opportunities exist only for white. Promotion prospects directly correlated with incompetence!
Analogy: Like in Kite Biomarin called Roche to send the cavalry to rescue the company. As in Kite it is being done by headcount reduction. Jeff A is a prominent example. Some executive and senior vice-presidents would go soon since they do not contribute but interfere by looking busy. Stock market is not impressed. Rarely companies ask the capable people who already left to return and help rebuild. Rather we may expect people streaming from Genentech and Roche following the CEO. However, they do not have right experience to match the Biomarin niche. Contraction expected, possibly 15% reduction in workforce